1. Home
  2. IGR vs OPT Comparison

IGR vs OPT Comparison

Compare IGR & OPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGR
  • OPT
  • Stock Information
  • Founded
  • IGR 2004
  • OPT 1984
  • Country
  • IGR United States
  • OPT Australia
  • Employees
  • IGR N/A
  • OPT N/A
  • Industry
  • IGR Finance Companies
  • OPT Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • IGR Finance
  • OPT Health Care
  • Exchange
  • IGR Nasdaq
  • OPT Nasdaq
  • Market Cap
  • IGR 721.1M
  • OPT 855.6M
  • IPO Year
  • IGR N/A
  • OPT 2020
  • Fundamental
  • Price
  • IGR $5.22
  • OPT $5.09
  • Analyst Decision
  • IGR
  • OPT Strong Buy
  • Analyst Count
  • IGR 0
  • OPT 1
  • Target Price
  • IGR N/A
  • OPT $12.00
  • AVG Volume (30 Days)
  • IGR 747.7K
  • OPT 40.1K
  • Earning Date
  • IGR 01-01-0001
  • OPT 03-03-2025
  • Dividend Yield
  • IGR 13.93%
  • OPT N/A
  • EPS Growth
  • IGR N/A
  • OPT N/A
  • EPS
  • IGR N/A
  • OPT N/A
  • Revenue
  • IGR N/A
  • OPT $261,859.00
  • Revenue This Year
  • IGR N/A
  • OPT N/A
  • Revenue Next Year
  • IGR N/A
  • OPT $46,864.26
  • P/E Ratio
  • IGR N/A
  • OPT N/A
  • Revenue Growth
  • IGR N/A
  • OPT N/A
  • 52 Week Low
  • IGR $3.88
  • OPT $1.79
  • 52 Week High
  • IGR $5.70
  • OPT $6.30
  • Technical
  • Relative Strength Index (RSI)
  • IGR 49.29
  • OPT 53.99
  • Support Level
  • IGR $5.23
  • OPT $4.77
  • Resistance Level
  • IGR $5.36
  • OPT $5.46
  • Average True Range (ATR)
  • IGR 0.07
  • OPT 0.32
  • MACD
  • IGR -0.00
  • OPT -0.11
  • Stochastic Oscillator
  • IGR 46.30
  • OPT 20.60

About IGR CBRE Global Real Estate Income Fund of Beneficial Interest

CBRE Clarion Global Real Estate Income Fund is the United States based diversified, closed-end management investment company. Its objective is high current income and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities located mainly in the developed markets of North America, Europe, Australia, and Asia. Its portfolio of investments consists of different sectors such as diversified, retail, industrial, residential, hotels, healthcare, and other sectors.

About OPT Opthea Limited

Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.

Share on Social Networks: